StocksRunner logo
mail
search
 
menu
 
Amgen
$298.24
+0.47%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
 
 

AMGN

 

Amgen

$298.24

 
+$1.39 | +0.47%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 346.85
 
 
MKT CAP
$ 160.37B
 
52W Low
$ 253.30
 
 
VOL
$ 1.52M
 
P/E Ratio
27.22
 
 
AVG VOL
$ 2.89M
 
RSI
62.32
 
 
TREND
Uptrend
 
 
 

AMGN Stock Rating

 
lock  Login to display Amgen (AMGN) recommendation from the last 90 days from financial news and social media.
 
 

AMGN Total Score

 
 
 
Today
-0.23
score
3.75
 
AMGN Stock Score
Strong Sell
Hold
Strong Buy
 
Based on 20 events in the last 90 days from financial news and social media. Last updated Jul 3, 2025 13:47 Wall St. time
 
 
 

Strengths

 

AMGN Rewards

 Earnings are forecast to grow

 

Risk Analysis

 

AMGN Risk Analysis

 Investors losing their confidence

 
 

Chart

 
 

$310.88   (-4.07%)

 
 
1year
6month
3month
1month
 

AMGN Risk Level

 

This Indicator assigning AMGN risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
AMGN Risk Level
LOW
HIGH

Risk Volatility

 

AMGN has Low Risk Level

Click here to check what is your level of risk

 

AMGN Analysts Opinion

 

AMGN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

AMGN Earnings Sentiment

 Above analyst estimates

AMGN Earnings Sentiment

 Reported a strong earnings

 
 

Rating

×
 

Rating

 
 

Momentum

×
 

Momentum

 

AMGN Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 

AMGN Activity Sentiment

 Investors losing their confidence

 

Future

×
 

Future

 

AMGN Future Sentiment

 Earnings are forecast to grow

 
 

AMGN Analysts Opinion

AMGN Analysts opinion is negative and it remained unchanged from the past 3 months

 

AMGN Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
75%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
25%
100%
 

AMGN Street Opinion 

AMGN Street view is extremely bullish and have positive views on the near-term outlook

 

AMGN Performance Sentiment

 
Sentiments overview associated with AMGN events and the stock performance.
 
75%
15%
Positive
Negative
15 out of 20
events present
3 out of 20
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
AMGN Latest Analysis +
 
 
 
StocksRunner

Explore our AMGN Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored AMGN Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our AMGN Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Earnings
mail
 
 

AMGN

 

Amgen

 
 

Current Price

 

$298.24

 
+$1.39 | +0.47%
 
AMGN Rating Score

Hold

 
52W High
$ 346.85
 
 
MKT CAP
$ 160.37B
 
52W Low
$ 253.30
 
 
VOL
$ 1.52M
 
P/E Ratio
27.22
 
 
AVG VOL
$ 2.89M
 
RSI
62.32
 
 
TREND
Uptrend
 
 
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 
 
 

AMGN Stock Rating

 
lock  Login to view Amgen (AMGN) recommendation from the last 90 days from financial news and social media.
 

Chart

 
 

$310.88   (-4.07%)

 
 
1year
6month
3month
1month
 
 
 
 
 

AMGN Latest Analysis

 
 
 

Noteworthy Tuesday Option Activity: AMGN DJT AR. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Amgen Inc (Symbol: AMGN) where a total of 15814 contracts have traded so far representing approximately 1.6 million underlying shares. That amounts to about 55.9% of

 

Tue Jul 1, 2025

$290.49 | +4.04%
 
Momentum

Paroxysmal Nocturnal Hemoglobinuria Market Set for Robust Growth During the Forecast Period (2025–2034) Owing to the Advancements in Complement Inhibitor Therapies | DelveInsight. Paroxysmal Nocturnal Hemoglobinuria Market Set for Robust Growth During the Forecast Period (2025–2034) Owing to the Advancements in Complement Inhibitor Therapies |. DelveInsight The paroxysmal nocturnal hemoglobinuria market is witnessing robust growth driven by increasing disease awareness improved diagnostics a

 

Tue Jul 1, 2025

$290.49 | +4.04%
 
Activity
Activity
Potential

Amgens Gastric Cancer Drug Improves Survival In Phase 3 Notes Ocular Side Effects. ) on Monday released data from the Phase 3 FORTITUDE-101 trial of first-line bemarituzumab plus chemotherapy (mFOLFOX6).The study met its primary endpoint of overall survival (OS) at a .Bemarituzumab plus chemotherapy demonstrated astatistically significant and clinically meaningful improvement in OS as compared toplacebo plus chemotherapy for unresectable locally advanced ormetastatic gastric or gastroesophageal

 

Mon Jun 30, 2025

$279.21 | +0.75%
 
Activity

Amgen Looks to Take Share of Booming Obesity Space: Will It Succeed?. Amgen aims to challenge obesity drug leaders with MariTide a potential monthly treatment now in late-stage trials.

 

Fri Jun 27, 2025

$277.13 | -0.71%
 
Activity

Analyst Views Mixed As Amgens Weight Loss/Diabetes Drug MariTide Shows Promise But Has Dose Issues. ) on Monday the full results from Part 1 of the Phase 2 study of .In the Phase 2 study MariTide demonstrated up to ~20% average weight loss in people living with obesity without Type 2 diabetes (T2D) compared with 2.6% in the placebo arm and up to ~17% average weight loss in people living with obesity with T2D compared with 1.4% in the placebo arm per the efficacy estimand.Weight loss had not pla

 

Tue Jun 24, 2025

$277.49 | +1.85%
 
Activity
Activity
Potential

Where Amgen Stands With Analysts. Across the recent three months 8 analysts have shared their insights on Amgen (NASDAQ:) expressing a variety of opinions spanning from ish to bearish.In the table below you'.ll find a summary of their recent ratings revealing the shifting sentiments over the past 30 days and comparing them to the previous months.0260000100000000230000200Providing deeper insights analysts have established 12-month price targets indicating an average target of $310.62 along wi

 

Tue Jun 24, 2025

$277.49 | +1.85%
 
Momentum

Amgen stock maintains Overweight rating at Piper Sandler despite GI data.

 

Tue Jun 24, 2025

$277.49 | +1.85%
 
Rating

Amgen Inc. (AMGN) Presents at Special Call (IR Call) Conference Transcript.

 

Tue Jun 24, 2025

$277.49 | +1.85%
 
Activity

Amgen falls despite positive weight loss trial results.

 

Mon Jun 23, 2025

$272.44 | -5.84%
 
Activity
Momentum

RESULTS FROM AMGENS PHASE 2 OBESITY STUDY OF MONTHLY MARITIDE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS. MariTide the First Monthly or Less Frequently Dosed Obesity Treatment Demonstrated Up to ~20% Average Weight Loss Without a Weight Loss Plateau and Delivered Significant Cardiometabolic Improvements at 52 Weeks In People Living With Obesity With Type 2 Diabetes MariTide Demonstrated...

 

Mon Jun 23, 2025

$272.44 | -5.84%
 
Activity

 
 
 
 
 
StocksRunner

Discover AMGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AMGN. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our AMGN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AMGN Stock trends

AMGN Stock performance

AMGN Stock analysis

AMGN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

UnAlert AMGN Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 

 
 
Post ×
 
0/666
joker